The extent of use of SGLT2 inhibitors in patients with type 2 diabetes in clinical practice: A study...
The extent of use of SGLT2 inhibitors in patients with type 2 diabetes in clinical practice: A study from India
About this item
Full title
Author / Creator
Publisher
Wolters Kluwer - Medknow Publications
Journal title
Language
English
Formats
Publication information
Publisher
Wolters Kluwer - Medknow Publications
Subjects
More information
Scope and Contents
Contents
Background and Aim: The cost of diabetes complication management is always much higher than the cost of diabetes treatment, even with novel and expensive molecules available. Thus, it is better to halt complications in the initial phase of the disease, rather than just treating hyperglycemia. Sodium-glucose co-transporter-2 inhibitor (SGLT-2i) is m...
Alternative Titles
Full title
The extent of use of SGLT2 inhibitors in patients with type 2 diabetes in clinical practice: A study from India
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_637777dab0964f638828573559baeb64
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_637777dab0964f638828573559baeb64
Other Identifiers
ISSN
2078-7685
E-ISSN
2078-7685
DOI
10.4103/JOD.JOD_81_20
